Oxford Nanopore Technologies plc
ONTTF
Price:
$2.12
Market Cap:
$1.51B
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; Prometh...[Read more]
Industry
Biotechnology
IPO Date
2021-10-15
Stock Exchange
PNK
Ticker
ONTTF
The ROE as of September 2024 (TTM) for Oxford Nanopore Technologies plc (ONTTF) is -43.29%
According to Oxford Nanopore Technologies plc’s latest financial reports and current stock price. The company's current ROE is -43.29%. This represents a change of 298.06% compared to the average of -10.87% of the last 4 quarters.
Oxford Nanopore Technologies plc (ONTTF) Historical ROE (quarterly & annually)
How has ONTTF ROE performed in the past?
The mean historical ROE of Oxford Nanopore Technologies plc over the last ten years is -39.33%. The current -43.29% ROE has changed 10.05% with respect to the historical average. Over the past ten years (40 quarters), ONTTF's ROE was at its highest in in the June 2020 quarter at 0%. The ROE was at its lowest in in the December 2021 quarter at -17.44%.
Average
-39.33%
Median
-37.90%
Minimum
-65.93%
Maximum
-13.12%
Oxford Nanopore Technologies plc (ONTTF) ROE by Quarter and Year
Discovering the peaks and valleys of Oxford Nanopore Technologies plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.85%
Maximum Annual ROE = -13.12%
Minimum Annual Increase = -50.04%
Minimum Annual ROE = -65.93%
| Year | ROE | Change |
|---|---|---|
| 2023 | -24.00% | 82.85% |
| 2022 | -13.12% | -44.88% |
| 2021 | -23.81% | -27.72% |
| 2020 | -32.94% | -50.04% |
| 2019 | -65.93% | 77.37% |
| 2018 | -37.17% | -38.47% |
| 2017 | -60.41% | 47.43% |
| 2016 | -40.98% | 6.09% |
| 2015 | -38.62% | -31.47% |
| 2014 | -56.36% | 52.61% |
Oxford Nanopore Technologies plc (ONTTF) Average ROE
How has ONTTF ROE performed in the past?
The current ROE of Oxford Nanopore Technologies plc (ONTTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-20.31%
5-year avg
-31.96%
10-year avg
-39.33%
Oxford Nanopore Technologies plc (ONTTF) ROE vs. Peers
How is ONTTF’s ROE compared to its peers?
Oxford Nanopore Technologies plc’s ROE is less than AgeX Therapeutics, Inc. (0%), less than Lineage Cell Therapeutics, Inc. (172.71%), greater than Cadrenal Therapeutics, Inc. Common Stock (-35.54%), greater than ImmuCell Corporation (-93.71%), greater than Reunion Neuroscience Inc. (-16.35%), greater than Braxia Scientific Corp. (-148.88%), greater than Algernon Pharmaceuticals Inc. (-1495.79%), greater than Awakn Life Sciences Corp. (-213.50%), less than Innovent Biologics, Inc. (292.48%), greater than Genscript Biotech Corporation (-2.22%), less than Nuvalent, Inc. (0%), greater than Nurix Therapeutics, Inc. (-20.31%), greater than Seer, Inc. (-28.83%), greater than Quantum-Si incorporated (-67.78%), greater than HCW Biologics Inc. (-21.26%), greater than MediciNova, Inc. (-34.01%), greater than null (-385.90%), greater than null (-13.37%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $27.76M | |
| 172.71% | $166.18M | |
| -35.54% | $12.79M | |
| -93.71% | $28.20M | |
| -16.35% | $13.12M | |
| -148.88% | $651.54K | |
| -1495.79% | $1.54M | |
| -213.50% | $2.42M | |
| 292.48% | $9.10B | |
| -2.22% | $2.96B | |
| 0% | $6.65B | |
| -20.31% | $1.59B | |
| -28.83% | $108.73M | |
| -67.78% | $142.36M | |
| -21.26% | $22.69M | |
| -34.01% | $76.02M | |
| -385.90% | $0 | |
| -13.37% | $0 |
Build a custom stock screener for Oxford Nanopore Technologies plc (ONTTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxford Nanopore Technologies plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Oxford Nanopore Technologies plc (ONTTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Oxford Nanopore Technologies plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Oxford Nanopore Technologies plc's ROE?
How is the ROE calculated for Oxford Nanopore Technologies plc (ONTTF)?
What is the highest ROE for Oxford Nanopore Technologies plc (ONTTF)?
What is the 3-year average ROE for Oxford Nanopore Technologies plc (ONTTF)?
What is the 5-year average ROE for Oxford Nanopore Technologies plc (ONTTF)?
How does the current ROE for Oxford Nanopore Technologies plc (ONTTF) compare to its historical average?